
GLP-1 Weight-Loss Boom Triggers Caution From Doctors
A Gallup survey finds 11% of American adults now use GLP-1 medications for weight loss, a rise linked with a measurable drop in obesity, but doctors warn that these drugs must be medically indicated, supervised, and used as part of multimodal therapy; long-term use and access issues remain, and some patients rely on surgery or lifestyle changes alongside GLP-1 for sustained results.













